Status:
NOT_YET_RECRUITING
SUPerficial ENDometriosis In Magnetic Resonance Imaging
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Collaborating Sponsors:
Euraxi Pharma
Conditions:
Endometriosis
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to determine the correlation between the diagnosis of Superficial endometriosis by the 3DT1 sequence on Magnetic resonance imaging and the histology obtained by laparoscopy...
Detailed Description
This is a prospective, multicenter, non-randomized study evaluating the diagnostic performance of Magnetic Resonance Imaging in superficial endometriosis. The duration of the patient's participation ...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Age ≥ 18 years;
- Non-menopausal patient;
- Patient scheduled for exploratory laparoscopy;
- Patient requiring a preoperative pelvic MRI
- Patient having been informed and having signed an informed consent form.
- Exclusion Criteria :
- Classic contraindications to magnetic resonance imaging;
- Contraindications to anesthesia for exploratory laparoscopy;
- Contraindication to surgery following the findings of magnetic resonance imaging results;
- Patient with endometrioma \> 4 cm;
- Patient with known deep endometriosis;
- Patient uncooperative with protocol requirements or unable to attend the center for scheduled visits;
- Pregnant woman or woman of childbearing age, without effective contraception or breastfeeding;
- Patient participating in another clinical trial, or during a period of exclusion from another clinical trial;
- Patient under guardianship, under curatorship or subject to legal protection, persons deprived of liberty by a judicial or administrative decision, persons subject to psychiatric care and admitted to a health or social establishment;
- Patient not beneficiary of a social security system
- Patient under State Medical Aid.
Exclusion
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT06195280
Start Date
April 1 2025
End Date
March 1 2026
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Blomet
Paris, France, 75015